A study to compare and evauate the analgesic effect of amitriptyline and pregabalin in acute phase of herpes zoster
Not Applicable
- Conditions
- Health Condition 1: null- patients with active herpes zoster
- Registration Number
- CTRI/2018/06/014475
- Lead Sponsor
- Department of anaesthesiology and critical care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
participants in acute phase of herpes zoster
Exclusion Criteria
participants with chronic illness on treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS ScoreTimepoint: 0, 2, 4, 6, 8, 10, 12 and 14 weeks
- Secondary Outcome Measures
Name Time Method patient satisficationTimepoint: 14 weeks